Sfoglia per Autore
Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia
1995 Sacchi, Stefano; Kantarjian, H; O'Brien, S; Cohen, Pr; Pierce, S; Talpaz, M.
Bcl-2 oncoprotein expression in acute myeloid leukemia
1995 Bensi, L; Longo, R; Vecchi, A; Messora, C; Garagnani, L; Bernardi, S; Tamassia, Mg; Sacchi, Stefano
P-GLYCOPROTEIN EXPRESSION IN ACUTE MYELOBLASTIC-LEUKEMIA ANALYZED BY IMMUNOCYTOCHEMISTRY AND FLOW-CYTOMETRY
1995 Longo, R; Bensi, L; Vecchi, A; Messora, C; Sacchi, Stefano
DETECTION OF PML-RAR-ALPHA FUSION TRANSCRIPT IN PH POSITIVE LEUKEMIA WITH ACUTE PROMYELOCYTIC PHENOTYPE LACKING THE T(15-17) CYTOGENETIC ABNORMALITY
1995 Emilia, G; Marasca, Roberto; Longo, G; Ferrari, Mg; Notohamiprodjo, M; Temperani, Paola; Sacchi, Stefano; Torelli, Giuseppe
the role of alpha-interpheron in essential thrombocytemia, polycythaemia vera and myelofibrosis with myeloid metaplasia ; a concise update
1995 Sacchi, Stefano
Factors that influence achievment of complete remission and its duration after polychemotherapy in follicular non Hodgikin's lymphoma.
1996 Liberati, Am; Di Clemente, F; Biscottini, B; Cinieri, S; De Angelis, V; De Renzo, A; Rotoli, B; Abate, G; Russo, F; Milani, S; Mustacchi, G; Ambrosi, L; Leoni, P; Mastria, A; Lorusso, V; Vecchi, A; Sacchi, Stefano; Palmieri, F; Volpe, E; Minischetti, Gadaleta; Dammacco, F; Di Costanzo, F; Brugiatelli, M; Grignani, F.
BCL-2 and adhesion molecule modulation induced by atra in non M3 leukemic blast cultures.
1996 Sacchi, Stefano; Terzi, A; Vanzanelli, P; Vecchi, A; Longo, R.
Phase I/II study of the biological activity of all-trans retinoic acid in patients with Ph1+ chronic myeloid leukemia.
1996 Sacchi, Stefano; M. B., Regazzi; G., Avvisati; G., Dastoli; P., Gallieni; C., Grassi; M., Lazzarino; A. M., Liberati; A. T., Maiolo; P. G., Pellicci; S., Rupoli; G., Visani; D., Russo
ALPHA-INTERFERON IN THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA: CLINICAL RESULTS AND EVALUATION OF ITS BIOLOGICAL EFFECTS ON THE HEMATOPOIETIC NEOPLASTIC CLONE.
1996 Sacchi, Stefano; L., Gugliotta; F., Papineschi; A. M., Liberati; S., Rupoli; C., Delfini; M., Ruggeri; L., Cavanna; A., Bucalossi; C., Ferrandina; M., Morselli; Torelli, Giuseppe
Intermittent treatment with all-trans retinoic acid (Atra) in patients with chronic myeloid leukemia in chronic phase.
1996 Russo, D; Regazzi, Mb; Sacchi, Stefano; Visani, G; Lazzarino, M; Pelicci, Pg; Dastoli, G; Galieni, P; Rupoli, S; Liberati, Am; Maiolo, A. T.
Long-term follow-up of alpha-interferon based regimens in patients with late chronic phase chronic myelogenous leukemia (CP-CML).
1996 Sacchi, Stefano; H., Kantarjian; S., O'Brien; M., Keating; E., Freireich; M., Talpaz
Effect of interferon-alpha (IFN-A) on different lymphocyte subpopulations in patients with chronic myeloid leukemia (CML).
1996 J., Cortes; Sacchi, Stefano; H., Kantarjian; M., Talpaz
In vivo biological response following low-dose interleukin-2 in complete remission B-cell non-Hodgkin's lymphoma patients. Italian Lymphoma Study Group (GISL).
1996 A., Vecchi; L., Cavanna; P., Avanzini; V., Callea; V., Velardi; N., Albi; P., Tartoni; L., Bensi; P., Valentini; R., Longo; Sacchi, Stefano
L'alfa INF nel trattamento delle sindromi mieloproliferative croniche
1997 Vanzarelli, P; Vinci, G; Spadafora, P; Fiorani, C; Terzi, A; Sacchi, Stefano
Early treatment decisions with interferon alpha (IFNalpha) therapy on early chronic phase myelogenous leukemia (CP-CML).
1997 Sacchi, Stefano; Kantarjian, Hm; Smith, T; O., Brien S; Pierce S., Kornablau S; Keating, Mj; Talpaz, M.
Epidermiological, diagnostic, therapeutic and prognostic aspects of essential thrombocithemia in a retrospective study of the GIMMC group in two thousand patients.
1997 Gugliotta, L; Marchioli, R; Fiacchini, M; Vianelli, N; Baravelli, S; Valdrè, L; De vivo, A; Marfisi, R; Radaelli, F; Garantini, L; Ambrosetto, A; Mazzucconi, Mg; Russo, D; Bazzan, M; Zaccaria, A; Finazzi, G; Grossi, A; Ruggeri, M; Pogliani, E; Sacchi, Stefano; Martelli, V; Barbui, T; Lazzarino, M.
Long-term follow-up results of alpha-interferon-based regimens in patients with late chronic myelogenous leukemia
1997 Sacchi, Stefano; Kantarjian, Hm; O'Brien, S; Beran, M; Koller, C; Pierce, S; Kornablau, S; Estey, E; Keating, Mj; Talpaz, M.
Factors that predict response and disease free survival in clinically advanced follicular lymphomas.
1997 Genua, A; Biscottini, B; Cinieri, S; Trottini, M; De Renzo, A; Rotoli, B; Tafuro, S; Abate, G; Milani, S; Mustacchi, G; Ambrosi, L; Leoni, P; Mastria, A; Vecchi, A; Sacchi, Stefano; Palmieri, F; Volpe, E; Azzolini, C; Dammacco, F; Di Costanzo, F; Caparotti, G; Grignani, F; De Angelis, V; Al Sharjiaby, N; Liberati, A. M.
Effects of interferon-alpha therapy on lymphocyte subpopulations in patients with chronic myeloid leukemia.
1997 Sacchi, Stefano; Cortes, J; Kantarjian, H; Talpaz, M.
All-trans retinoic acid in hematological malignancies, an update. GER (Gruppo Ematologico Retinoidi)
1997 Sacchi, Stefano; Russo, D; Avvisati, G; Dastoli, G; Lazzarino, M; Pelicci, Pg; Bonora, Mr; Visani, G; Grassi, C; Iacona, I; Luzzi, L; Vanzanelli, P.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia | 1-gen-1995 | Sacchi, Stefano; Kantarjian, H; O'Brien, S; Cohen, Pr; Pierce, S; Talpaz, M. | |
Bcl-2 oncoprotein expression in acute myeloid leukemia | 1-gen-1995 | Bensi, L; Longo, R; Vecchi, A; Messora, C; Garagnani, L; Bernardi, S; Tamassia, Mg; Sacchi, Stefano | |
P-GLYCOPROTEIN EXPRESSION IN ACUTE MYELOBLASTIC-LEUKEMIA ANALYZED BY IMMUNOCYTOCHEMISTRY AND FLOW-CYTOMETRY | 1-gen-1995 | Longo, R; Bensi, L; Vecchi, A; Messora, C; Sacchi, Stefano | |
DETECTION OF PML-RAR-ALPHA FUSION TRANSCRIPT IN PH POSITIVE LEUKEMIA WITH ACUTE PROMYELOCYTIC PHENOTYPE LACKING THE T(15-17) CYTOGENETIC ABNORMALITY | 1-gen-1995 | Emilia, G; Marasca, Roberto; Longo, G; Ferrari, Mg; Notohamiprodjo, M; Temperani, Paola; Sacchi, Stefano; Torelli, Giuseppe | |
the role of alpha-interpheron in essential thrombocytemia, polycythaemia vera and myelofibrosis with myeloid metaplasia ; a concise update | 1-gen-1995 | Sacchi, Stefano | |
Factors that influence achievment of complete remission and its duration after polychemotherapy in follicular non Hodgikin's lymphoma. | 1-gen-1996 | Liberati, Am; Di Clemente, F; Biscottini, B; Cinieri, S; De Angelis, V; De Renzo, A; Rotoli, B; Abate, G; Russo, F; Milani, S; Mustacchi, G; Ambrosi, L; Leoni, P; Mastria, A; Lorusso, V; Vecchi, A; Sacchi, Stefano; Palmieri, F; Volpe, E; Minischetti, Gadaleta; Dammacco, F; Di Costanzo, F; Brugiatelli, M; Grignani, F. | |
BCL-2 and adhesion molecule modulation induced by atra in non M3 leukemic blast cultures. | 1-gen-1996 | Sacchi, Stefano; Terzi, A; Vanzanelli, P; Vecchi, A; Longo, R. | |
Phase I/II study of the biological activity of all-trans retinoic acid in patients with Ph1+ chronic myeloid leukemia. | 1-gen-1996 | Sacchi, Stefano; M. B., Regazzi; G., Avvisati; G., Dastoli; P., Gallieni; C., Grassi; M., Lazzarino; A. M., Liberati; A. T., Maiolo; P. G., Pellicci; S., Rupoli; G., Visani; D., Russo | |
ALPHA-INTERFERON IN THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA: CLINICAL RESULTS AND EVALUATION OF ITS BIOLOGICAL EFFECTS ON THE HEMATOPOIETIC NEOPLASTIC CLONE. | 1-gen-1996 | Sacchi, Stefano; L., Gugliotta; F., Papineschi; A. M., Liberati; S., Rupoli; C., Delfini; M., Ruggeri; L., Cavanna; A., Bucalossi; C., Ferrandina; M., Morselli; Torelli, Giuseppe | |
Intermittent treatment with all-trans retinoic acid (Atra) in patients with chronic myeloid leukemia in chronic phase. | 1-gen-1996 | Russo, D; Regazzi, Mb; Sacchi, Stefano; Visani, G; Lazzarino, M; Pelicci, Pg; Dastoli, G; Galieni, P; Rupoli, S; Liberati, Am; Maiolo, A. T. | |
Long-term follow-up of alpha-interferon based regimens in patients with late chronic phase chronic myelogenous leukemia (CP-CML). | 1-gen-1996 | Sacchi, Stefano; H., Kantarjian; S., O'Brien; M., Keating; E., Freireich; M., Talpaz | |
Effect of interferon-alpha (IFN-A) on different lymphocyte subpopulations in patients with chronic myeloid leukemia (CML). | 1-gen-1996 | J., Cortes; Sacchi, Stefano; H., Kantarjian; M., Talpaz | |
In vivo biological response following low-dose interleukin-2 in complete remission B-cell non-Hodgkin's lymphoma patients. Italian Lymphoma Study Group (GISL). | 1-gen-1996 | A., Vecchi; L., Cavanna; P., Avanzini; V., Callea; V., Velardi; N., Albi; P., Tartoni; L., Bensi; P., Valentini; R., Longo; Sacchi, Stefano | |
L'alfa INF nel trattamento delle sindromi mieloproliferative croniche | 1-gen-1997 | Vanzarelli, P; Vinci, G; Spadafora, P; Fiorani, C; Terzi, A; Sacchi, Stefano | |
Early treatment decisions with interferon alpha (IFNalpha) therapy on early chronic phase myelogenous leukemia (CP-CML). | 1-gen-1997 | Sacchi, Stefano; Kantarjian, Hm; Smith, T; O., Brien S; Pierce S., Kornablau S; Keating, Mj; Talpaz, M. | |
Epidermiological, diagnostic, therapeutic and prognostic aspects of essential thrombocithemia in a retrospective study of the GIMMC group in two thousand patients. | 1-gen-1997 | Gugliotta, L; Marchioli, R; Fiacchini, M; Vianelli, N; Baravelli, S; Valdrè, L; De vivo, A; Marfisi, R; Radaelli, F; Garantini, L; Ambrosetto, A; Mazzucconi, Mg; Russo, D; Bazzan, M; Zaccaria, A; Finazzi, G; Grossi, A; Ruggeri, M; Pogliani, E; Sacchi, Stefano; Martelli, V; Barbui, T; Lazzarino, M. | |
Long-term follow-up results of alpha-interferon-based regimens in patients with late chronic myelogenous leukemia | 1-gen-1997 | Sacchi, Stefano; Kantarjian, Hm; O'Brien, S; Beran, M; Koller, C; Pierce, S; Kornablau, S; Estey, E; Keating, Mj; Talpaz, M. | |
Factors that predict response and disease free survival in clinically advanced follicular lymphomas. | 1-gen-1997 | Genua, A; Biscottini, B; Cinieri, S; Trottini, M; De Renzo, A; Rotoli, B; Tafuro, S; Abate, G; Milani, S; Mustacchi, G; Ambrosi, L; Leoni, P; Mastria, A; Vecchi, A; Sacchi, Stefano; Palmieri, F; Volpe, E; Azzolini, C; Dammacco, F; Di Costanzo, F; Caparotti, G; Grignani, F; De Angelis, V; Al Sharjiaby, N; Liberati, A. M. | |
Effects of interferon-alpha therapy on lymphocyte subpopulations in patients with chronic myeloid leukemia. | 1-gen-1997 | Sacchi, Stefano; Cortes, J; Kantarjian, H; Talpaz, M. | |
All-trans retinoic acid in hematological malignancies, an update. GER (Gruppo Ematologico Retinoidi) | 1-gen-1997 | Sacchi, Stefano; Russo, D; Avvisati, G; Dastoli, G; Lazzarino, M; Pelicci, Pg; Bonora, Mr; Visani, G; Grassi, C; Iacona, I; Luzzi, L; Vanzanelli, P. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile